There are two kinds of mining guys in the public markets – the market-friendly corporate guy, who can raise money, navigate a boardroom, and put out a nice news…
ASX
The CPH circus looks to be leaving town after Canadian listed PharmaCielo (PCLO.V) made an all-scrip AUD $122M offer to acquire Creso Pharma (CPH.ASX), which equated to AUD 0.63…
A late Fumble today folks – been one of those weeks where no matter how much I flooded my body with Berocca it just wouldn’t respond 🙁 Good to…
The footy season has wrapped up in Oz and things ended the way they should according to the laws of the Animal Kingdom. The Eagles beat the Magpies and…
We’re back with the fumble. Last week I was indisposed, apologies. A sexy nurse was slicing open my right arm and stuffing a camera through the artery all the…
Muay Thai is the national sport here in my adopted homeland. Known as ‘the science of eight limbs‘ it’s a brutal contest – a knee or elbow to the…
I still remember what it felt like to wake up and realize it was Friday when I was entombed in a corporate cubicle. Everything was sweeter – even the…
It’s been a long ten months for CannPal Animal Therapeutics (CP1.ASX) shareholders having watched their investment hover around the $0.20 IPO issue price. While other ASX cannabis names have…
On the surface, the rights issue announced by Creso Pharma (CPH.ASX) looks to be a decent deal for long-suffering shareholders, albeit it a little unusual. The rights issue is…
The Australian government has really dropped the ball when it comes to easy access to medicinal cannabis. Want proof? Sometimes all you need is a picture, like the one…